Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks
Completed · Phase 2 · Has a placebo group
Conditions studied: Rheumatoid Arthritis
In brief
The study's objective is to compare the efficacy of 3 dose levels of oral CP-690,550 monotherapy (5 mg, 15 mg, and 30 mg twice daily \[BID\]) versus placebo administered over 6 weeks for the treatment of the signs and symptoms of subjects with active rheumatoid arthritis (RA).
Key facts
- Study ID
- NCT00147498
- Run by
- Pfizer
- People needed
- 264
- Starts
- 2005-01-01
- Expected to finish
- 2006-06-01
- Last updated by the study team
- 2013-01-30
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject has a history of inadequate response to at least 1, but no more than 4, of the following DMARDs: sulfasalazine, injectable gold, methotrexate, leflunomide, cyclosporine, or a thiopurine derivative (azathioprine or 6-mercaptopurine)
You may not qualify if…
- Current Therapy With Any DMARD Or Biologic
Where it is running
- Pfizer Investigational Site — Clearwater, Florida, United States
- Pfizer Investigational Site — Miami, Florida, United States
- Pfizer Investigational Site — New Port Richey, Florida, United States
- Pfizer Investigational Site — Ocala, Florida, United States
- Pfizer Investigational Site — Orlando, Florida, United States
- Pfizer Investigational Site — Port Richey, Florida, United States
- Pfizer Investigational Site — Tampa, Florida, United States
- Pfizer Investigational Site — Dubuque, Iowa, United States
- Pfizer Investigational Site — Dubuque, Iowa, United States
- Pfizer Investigational Site — Concord, New Hampshire, United States
- Pfizer Investigational Site — Plainview, New York, United States
- Pfizer Investigational Site — Charlotte, North Carolina, United States
- Pfizer Investigational Site — Hickory, North Carolina, United States
- Pfizer Investigational Site — Hickory, North Carolina, United States
- Pfizer Investigational Site — Dayton, Ohio, United States
- Pfizer Investigational Site — Ducansville, Pennsylvania, United States
- Pfizer Investigational Site — Johnstown, Pennsylvania, United States
- Pfizer Investigational Site — Charleston, South Carolina, United States
- Pfizer Investigational Site — Columbia, South Carolina, United States
- Pfizer Investigational Site — Nashville, Tennessee, United States
- Pfizer Investigational Site — Dallas, Texas, United States
- Pfizer Investigational Site — Everett, Washington, United States
- Pfizer Investigational Site — Tacoma, Washington, United States
- Pfizer Investigational Site — Ghent, Belgium
- Pfizer Investigational Site — Upland, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.